FDA Inspection 1178319 — ART Reproductive Center, LLC
The FDA completed an inspection of ART Reproductive Center, LLC on August 15, 2022 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 15, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Beverly Hills, CA (United States)